Hsbc Holdings PLC Heron Therapeutics, Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q3 2024
A detailed history of Hsbc Holdings PLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 49,689 shares of HRTX stock, worth $84,471. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,689
Previous 31,943
55.56%
Holding current value
$84,471
Previous $111,000
11.71%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding HRTX
# of Institutions
175Shares Held
121MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$45.4 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$15 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$14.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$14.2 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$11.9 Million28.8% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $202M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...